Direxion Daily S&P Biotech Bear 3X Shares (LABD)

NYSEArca

7.25
-0.03 (-0.41%)
Updated Aug 18, 4:32 PM ET
AI Rating
Sell
Overall Score
29
Trend
25
Momentum
29
Risk
34

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

Direxion Daily S&P Biotech Bear 3X Shares is trading at $7.25, down 0.41% on the session. The 50 day average sits at $9.33 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 40, which reads as weak, and MACD is bearish crossover. Volume is volume spike.

The nearest support is around $6.68 with resistance near $9.06, so that band frames the current range. Average daily movement is roughly $0.66, or about 9.2% of the share price, which is what any stop placement has to allow for. The overall health score of 29 out of 100 combines a trend score of 25, momentum of 29 and a risk score of 34.

Technical indicators

RSI (14)
40.0
weak
MACD
-0.460
bearish crossover
SMA 20
8.32
SMA 50
9.33
SMA 200
--
unknown
ATR (14)
0.66
avg daily range
Support
6.68
Resistance
9.06
Volume vs 20d
1.92x
volume spike
Volatility
75.0%
annualised
1 month
-11.87%
3 months
-43.88%

About Direxion Daily S&P Biotech Bear 3X Shares

The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.